Stocktoria
Marker Therapeutics, Inc. MRKR
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-11-08
Marker Therapeutics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -363.5% | -168.7% | -440.4% | -563.3% | -3179.3% | -5777.2% | -10567.3% | -71930.1% | -6271.1% | — |
| Net margin | -343.0% | -162.8% | -248.8% | -851.9% | -3372.7% | -5741.2% | -10050.9% | -71826.3% | -5999.1% | — |
| FCF margin | — | — | — | — | — | — | -8752.3% | -7101.0% | -4610.1% | — |
| Return on assets | -63.8% | -48.7% | -48.1% | -87.0% | -61.5% | -62.9% | -46.2% | -238.1% | -212.0% | -31.0% |
| Return on equity | -72.4% | -57.8% | -58.6% | -152.7% | -95.2% | -105.0% | -48.6% | -249.3% | -300.2% | -39.7% |
| Current ratio | 8.39 | 6.36 | 5.57 | 2.14 | 3.56 | 3.81 | 22.83 | 22.11 | 3.40 | 4.56 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.